| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.081 | 0.6 |